![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 02, 2014 12:29:01 PM
One burning question that will be answered in the coming months, will be 'is the patent infringement filing by Antares enough to delay Medacs' entry into the market place? Yes, the CP and TI did not work, but the original "First Complaint" v Medac is still working its way through the legal process with many steps to go through (assuming their is no pending settlement) and also, the "Notice of Appeal by Plaintiff Antares Pharma, Inc" is in process. Will these things give Medac pause to launch, will these things motivate Medac to settle and visa versa??
I don't think any gain from further litigation will be known for a few months. Until then, the wheels of justice, so to speak, are in motion. But ultimately, imo, there will be a settlement between both parties.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM